Carcinoma, non-small-cell lung - Globe Thesis

Keyword [Carcinoma, non-small-cell lung] Result: 41 - 60 \| Page: 3 of 5
41.	Study Of Dosimetry In Radiation Therapy For Intermediate And Advanced Stage NSCLC
42.	Study On The Distribution Of Effective Radiation Dose And Character Of Toxic Side Effect When ¹²⁵Ⅰ Seeds Were Administrated To Treat The Patients With NSCLC
43.	Prognostic Value Of Serial [18f]fluorodeoxyglucose PET-CT Up Take In Stage Ⅲ Patients With Non-small Cell Lung Cancer Treated By Concurrent Chemoradiotherapy
44.	Detection Of EGFR Gene Mutations In Peripheral Blood And Tumor Tissues Of Patients With Non-small Cell Lung Cancer
45.	The Chemotherapy Efficacy And Prognosis Analysis Of Advanced Non Small Cell Lung Cancer
46.	Polymorphisms In ERCC1, RRM1 Genes And Sensitivity To Gemcitabine /cisplatin Chemotherapy In Advanced Non-small Cell Lung Cancer
47.	Study On The Expression Of SEGFR By 11C-PD153035 PET/CT In Patients With Non-small Cell Lung Cancer
48.	A Clinical Research Of Xuebijing-injection Applied To The Chemotherapy Of Advanced NSCLC With Yuzu Feiluo Syndrome
49.	Growth And Mechanism Of Octreotide Combined With The Beat Of Chemotherapy On Lung Adenocarcinoma A549Cells
50.	Tumor-targeting Magnetic Lipoplex Delivery Of ShRNA Suppresses IGF-1R Overexpression Of Lung Cancer A549Cells In Vitro And In Vivo
51.	Clinical Significance Of Detection Of Plasma-Based EGFR And KRAS Mutations In Patients With Advanced NSCLC
52.	Expression Of Ki-67and Livin Proteins In Human Non-Small Cell Lung Cancer
53.	Gemcitabine Combined With Cisplatin As Adjuvant Chemotherapy In Resected Non-small Cell Lung Cancer-A Retrospective Analysis With100Cases
54.	Co-expression Of Hypoxia-inducible Factor-1α And Hepatocyte Growth Factor In Non-small-cell Lung Cancer And Their Association With Lymphangiogenesis
55.	The Prognositic Value Of Serum CEA Or CYFRA21-1Level For The Non-small-cell Cancer Patients Undergone Adjuvant Chemotherapy
56.	A Study On The Expression Of Chemokine CXCL12/CXCR4in Non-small Cell Lung Cancer
57.	Value Of The Osteopontin-Positive Macrophage For Predicting The Prognosis Of Non-Small-Cell Lung Cancer Patients
58.	Clinical Study Of¹⁸F-FDG Imaging And CT Perfusion Evaluate Efficacy And Prognosis In Advanced Non-small Cell Lung Cancer
59.	Correlations Among Prognosis, Metastasis And Expression Of Rac1and NF-κB P65in Non-Small Cell Lung Cancer
60.	The Roles Of EMT And IGF-1R In The Acquired Resistance Of Non-small Cell Lung Cancer To Epidermal Growth Factor-tyrosine Kinase Inhibitors
<<First <Prev Next> Last>> Jump to